 ber of performance shares that the CEO could be entitled to if all conditions were fully achieved. Savings shares, in which the CEO has 
invested to become eligible to participate in the Plans, are not included in the table. Final awards will be increased by a dividend compensation factor to compensate for 
dividends decided over the vesting period and the factor is determined at the date the award vests. The CEO participated with 22,500 saving shares in each of the Plans 
2019, 2020, 2021, 2022, 2023 and 2024. For each saving share invested and maintained in accordance with the respective Plan, the participant may receive up to eight 
performance shares at the end of the vesting period, i.e. a maximum allocation of 180,000 performance shares for the CEO under each of the Plans 2019 , 2020 , 2021 , 
2022, 2023 and 2024, which will be received as class B shares in the Company. The maximum value per each participant’s share rights under the respective Plan is, 
however, limited to ten ti iddargatan 12A | Sweden 
5 (5) 
 
Table 3 – Change of remuneration and company performance over the last five reported financial years (RFY) (EUR)(1) 
Annual change RFY-3 vs RFY -4 RFY-2 vs RFY -3 RFY-1 vs RFY -2 RFY vs RFY -1 RFY 202 4 
Director’s remuneration 
CEO remuneration +57,172 ( +6.3%) +2,344,357 (+242.2%) +448,562 (+13.5%) -916,178 ( -24.4%) 2,844,756(2) 
Company’s performance 
Group EBIT(3) (operating profit) +98,057,403 ( +159.8%) -104,229,690 ( -65.4%)(6) +6,208,100 (+11.3%) +8,967,041 (+14 .6%) 70,351,215 
Group EBITDA(4) +112,896,783 ( +71.7%) -53,356,125 ( -19.7%)(6) +26,732,537 (+12.3%) +41,116,248 (+16 .9%) 284,908,468 
Average remuneration on a full -time equivalent basis of employees 
Employees of the Company(5) +8,767 (+7.4%) -15,585 ( -12.2%) +25,976 (+23.2%) +20,655 (+15.0 %) 158,578 
 
(1) Amounts paid in SEK but stated in EUR have been calculated on the basis of an exchange rate of EUR/S EK 11.431 (Medi cover’s YTD average rate). 
(2) Total remuneration of the  remuneration of the CEO as set out in column 5 of Table 1 above. 
(3) Earnings before interest and tax. 
(4) Earnings before interest, other financial income/(expense), tax, amortisation, depreciation and impairment, other income/(costs) and share of profit/(loss) of associates. 
(5) Excluding members of the group executive management. The renumerations consists of base salary / fees, other benefits, variable renumeration, extraordinary items 
and pension expense, which is equal as the renumeration to CEO (Table 1). The average renumeration has been calculated by dividing the total renumeration with the 
average number of full -time employees in the Company, excluding the group executive management . 
(6) EBIT and EBITDA for the financial year 2022 have been restated for IFRS 17 compared to the remuneration report 2022. 
 
___________ 
 
Stockholm in March 2025 
Medicover AB (publ) 
The board of directors